Neurology

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical AffairsPliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif.,…

7 months ago
Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of BoardCurve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business…

7 months ago
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP StudyHelius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study

Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study

-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI…

7 months ago
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery diseaseGE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary…

7 months ago
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell TherapiesEvotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based…

7 months ago
TeleSpecialists’ TeleCare Software Achieves HITRUST i1 Certification, Elevating Data Protection and Cybersecurity StandardsTeleSpecialists’ TeleCare Software Achieves HITRUST i1 Certification, Elevating Data Protection and Cybersecurity Standards

TeleSpecialists’ TeleCare Software Achieves HITRUST i1 Certification, Elevating Data Protection and Cybersecurity Standards

HITRUST certification affirms TeleSpecialists' commitment to leading security practices to protect sensitive information FORT MYERS, Fla., Sept. 25, 2024 /PRNewswire/…

7 months ago
Linus Health to Unveil New Tools for Earlier Dementia Detection at AAFP’s FMX ’24Linus Health to Unveil New Tools for Earlier Dementia Detection at AAFP’s FMX ’24

Linus Health to Unveil New Tools for Earlier Dementia Detection at AAFP’s FMX ’24

Chief Strategy Officer Dr. John Showalter will also explain during FMX Med Talk why early detection of cognitive impairment by…

7 months ago
CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet NeurologyCENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

Rostock International Parkinson's Disease (ROPAD) Study demonstrates a significant link between the RAB32 gene variant and Parkinson's disease, further supporting…

7 months ago
FONDAZIONE PRADA PRESENTS “PRESERVING THE BRAIN: A CALL TO ACTION” IN MILANFONDAZIONE PRADA PRESENTS “PRESERVING THE BRAIN: A CALL TO ACTION” IN MILAN

FONDAZIONE PRADA PRESENTS “PRESERVING THE BRAIN: A CALL TO ACTION” IN MILAN

MILAN, Sept. 25, 2024 /PRNewswire/ -- The new edition of "Preserving the Brain," part of Fondazione Prada's "Human Brains" project…

7 months ago
Altamira Therapeutics Provides Business Update and First Half 2024 Financial ResultsAltamira Therapeutics Provides Business Update and First Half 2024 Financial Results

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within…

8 months ago